
About Citi Neuro Centre Private Limited
Data last updated:
Citi Neuro Centre Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 28 October 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74900TG2014PTC096132.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.95 Cr. It is led by directors including Sreenivas Pyata and Ala Reddy Venkateshwer.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.8 – 2 – 293/82/A/443 Jubilee Hills Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹44,776, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹8.24 Lakh and EBITDA of ₹44,551 (EBITDA margin 99.5%). Revenue has declined at a compounded annual rate (CAGR) of 85% over five years.
The company is associated with 1 brand: Citi Neuro Centre. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.08 Cr; the latest was in February 2018.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website citineurocentre.com.
Company details
Contact details
Citi Neuro Centre Private Limited's registered office is in Hyderabad, Telangana. Its website is citineurocentre.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.8 – 2 – 293/82/A/443 Jubilee Hills Hyderabad, Telangana, India – 500034
- IndustryHealthcare, Hospitals
To see the full contact details of Citi Neuro Centre Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Citi Neuro Centre operates one associated brand: Citi Neuro Centre. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers neurology, neurosurgery, and medical services across multiple branches. | citineurocentre.com |
Financials of Citi Neuro Centre Private Limited
FY 2025 filings availableCiti Neuro Centre Private Limited reported revenue of ₹44,776 (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 85%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44,551 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.5% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Citi Neuro Centre Private Limited, buy the company report.
Board of directors of Citi Neuro Centre Private Limited
Citi Neuro Centre has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreenivas Pyata | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
| Ala Reddy Venkateshwer | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
| Arradi Vamshidhar | Director | 28 Oct 2014 | 12 Years 0 Months | Current |
Auditor
Citi Neuro Centre Private Limited is audited by VNK & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VNK & Associates | FY 2022 | 015492S |
Shareholding
The shareholding of Citi Neuro Centre Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Citi Neuro Centre Private Limited, buy the company report.
Deals & funding
Citi Neuro Centre Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.08 Cr; the latest was in February 2018.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2018 | Funding round | ₹1.75 Cr | Investors: 3 individuals |
| May 2016 | Funding round | ₹2.6 Cr | Investors: 4 individuals |
| Feb 2016 | Funding round | ₹1.73 Cr | Investors: 3 individuals |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Citi Neuro Centre Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Citi Neuro Centre Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Citi Neuro Centre Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Citi Neuro Centre Private Limited has 12 board changes on record since 2014: 3 appointments and 9 cessations. The latest: Buchipudi Reddy Sambasiva ceased to be Director on 22 Feb 2021.
3 earlier events are in the company report.
Frequently asked questions
Citi Neuro Centre is an active private limited company based in Hyderabad, Telangana, India. The company works in hospitals, within the healthcare industry. It was incorporated on 28 October 2014 (12+ years old) and is registered under CIN U74900TG2014PTC096132.
Citi Neuro Centre has 3 current directors:
- Sreenivas Pyata - Director
- Ala Reddy Venkateshwer - Director
- Arradi Vamshidhar - Director
The latest financial statements of Citi Neuro Centre on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Citi Neuro Centre is U74900TG2014PTC096132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Citi Neuro Centre was incorporated on 28 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Citi Neuro Centre has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.08 Cr; the latest was in February 2018.
Buchipudi Reddy Sambasiva ceased to be Director on 22 Feb 2021. Bhargava Prasad Cheerla ceased to be Director on 04 Jan 2021. Chakrala Kishore Rathna ceased to be Director on 04 Jan 2021. Citi Neuro Centre has 12 board changes on record in total.
Citi Neuro Centre can be reached through the website citineurocentre.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Citi Neuro Centre is at H.No.8 – 2 – 29382A443 Jubilee Hills Hyderabad, Telangana, India – 500034.
Citi Neuro Centre operates in the healthcare industry, in the hospitals segment.

